Institutional investors purchased a net $6.1 million shares of SRPT during the quarter ended September 2016, and now own 80.13% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JEFFERIES INVESTMENT ADVISERS LL... Bought 1.6 Million shares of Sarepta Therapeutics Inc
MILLENNIUM MANAGEMENT LLC Bought 1.6 Million shares of Sarepta Therapeutics Inc